Role of PKCβ in hepatocellular carcinoma cells migration and invasion in vitro: A potential therapeutic target

Clinical and Experimental Metastasis

Volumn 26, Issue 3, 2009, Pages 189-195

  Guo, Kun ^a,b   Li, Yan ^a,b   Kang, Xiaonan ^b   Sun, Lu ^b   Cui, Jiefeng ^a,b   Gao, Dongmei ^a   Liu, Yinkun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

DNA microarray; Hepatocellular carcinoma; Metastasis; PKC

Indexed keywords

ENZASTAURIN; PROTEIN KINASE C BETA; INDOLE DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CANCER INVASION; CELL MOTION; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; INDOLES; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE C; RNA INTERFERENCE; TETRADECANOYLPHORBOL ACETATE;

EID: 61449206026     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-008-9230-y     Document Type: Article

References (25)

1. JW Sturm M Keese 2004 Multimodal treatment of hepatocellular carcinoma (HCC) Onkologie 27 294 303 10.1159/000077982
2. P Rougier E Mitry JC Barbare 2007 Hepatocellular carcinoma (HCC): an update Semin Oncol 34 12 20 10.1053/j.seminoncol.2007.01.007
3. J Taieb JC Barbare P Rougier 2006 Medical treatments for hepatocellular carcinoma (HCC): what's next? Ann Oncol 17 308 314 10.1093/annonc/mdl279
4. Y Li B Tian J Yang 2004 Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics J Cancer Res Clin Oncol 130 460 468 10.1007/s00432-004-0564-9
5. Y Li ZY Tang SL Ye 2001 Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97 World J Gastroenterol 7 630 636
6. M Mareel A Leroy M Bracke 1998 Cellular and molecular mechanisms of metastasis as applied to carcinomatous meningitis J Neurooncol 38 97 102 10.1023/A:1005954002922
7. DS Hoon M Kitago J Kim 2006 Molecular mechanisms of metastasis Cancer Meta Rev 25 203 220 10.1007/s10555-006-8500-x
8. R Wadlow S Ramaswamy 2005 DNA microarrays in clinical cancer research Curr Mol Med 5 111 120 10.2174/1566524053152834
9. S Mandruzzato 2007 Technological platforms for microarray gene expression profiling Adv Exp Med Biol 593 12 18 10.1007/978-0-387-39978-2-2
10. TW Bauer W Liu F Fan 2005 Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice Cancer Res 65 7775 7781
11. LF Yu J Wang B Zou 2007 XAF1 mediates apoptosis through an extracellular signal-regulated kinase pathway in colon cancer Cancer 109 1996 2003 10.1002/cncr.22624
12. T Ishizuka K Kajita Y Natsume 2004 Protein kinase C (PKC) beta modulates serine phosphorylation of insulin receptor substrate-1 (IRS-1)-effect of overexpression of PKCbeta on insulin signal transduction Endocr Res 30 287 299 10.1081/ERC-120039580
13. J Koivunen V Aaltonen J Peltonen 2006 Protein kinase C (PKC) family in cancer progression Cancer Lett 235 1 10 10.1016/j.canlet.2005.03.033
14. AJ Redig LC Platanias 2007 The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis J Interferon Cytokine Res 27 623 636 10.1089/jir.2007.0007
15. M Fährmann 2008 Targeting protein kinase C (PKC) in physiology and cancer of the gastric cell system Curr Med Chem 15 1175 1191 10.2174/092986708784310413
16. D Xenaki A Pierce N Underhill-Day 2004 Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKCbetaII Cell Signal 16 145 156 10.1016/S0898-6568(03)00101-3
17. K Saito E Ito Y Takakuwa 2003 In situ observation of mobility and anchoring of PKCbetaI in plasma membrane FEBS Lett 541 126 131 10.1016/S0014-5793(03)00324-7
18. A Miura T Ishizuka Y Kanoh 1999 Effect of tumor necrosis factor-alpha on insulin signal transduction in rat adipocytes: relation to PKCbeta and zeta translocation Biochim Biophys Acta 1449 227 238
19. N Das Evcimen GL King 2007 The role of protein kinase C activation and the vascular complications of diabetes Pharmacol Res 55 498 510 10.1016/j.phrs.2007.04.016
20. B Guo TT Su DJ Rawlings 2004 Protein kinase C family functions in B-cell activation Curr Opin Immunol 16 367 373 10.1016/j.coi.2004.03.012
21. JA Taylor NV Naoumov 2005 The potential of RNA interference as a tool in the management of viral hepatitis J Hepatol 42 139 144 10.1016/j.jhep.2004.10. 022
22. I Bantounas LA Phylactou JB Uney 2004 RNA interference and the use of small interfering RNA to study gene function in mammalian systems J Mol Endocrinol 33 545 557 10.1677/jme.1.01582
23. U Troller R Zeidman K Svensson 2001 A PKCbeta isoform mediates phorbol ester-induced activation of Erk1/2 and expression of neuronal differentiation genes in neuroblastoma cells FEBS Lett 508 126 130 10.1016/S0014-5793(01)03043-5
24. L Saraiva P Fresco E Pinto 2004 Characterization of phorbol esters activity on individual mammalian protein kinase C isoforms, using the yeast phenotypic assay Eur J Pharmacol 491 101 110 10.1016/j.ejphar.2004.03.035
25. AP Fields NR Murray 2008 Protein kinase C isozymes as therapeutic targets for treatment of human cancers Adv Enzyme Regul 48 166 178 10.1016/j.advenzreg. 2007.11.014